Skip to main content

Table 1 Characteristics of studies related to the associations of rs50515 and rs11591147 with lipids levels

From: What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis

Author

Year

Ethnicity

Type of study

Sample size

SNP

Genotyping method

Age(year)

Sex(M/F)

MAF (%)

HWE

He, X M [27]

2016

Asians

C-C

233

rs505151

PCR-RFLP

63.95 ± 12.35

130/103

13.9

0.015

Jeenduang, N1 [28]

2015

Asians

Cohort

307

rs505151

PCR-RFLP

NA

97/210

1.95

0.727

Jeenduang, N2 [28]

2015

Asians

Cohort

188

rs505151

PCR-RFLP

NA

38/150

1.06

0.883

Yuqian, Mo [29]

2015

Asians

C-C

100

rs505151

TaqMan

56.4 ± 11.7

58/42

7.19

0.000

Anderson, J M1 [30]

2014

Caucasians

C-C

171

rs505151

PCR-RFLP

47 ± 7

108/55

12.6

NA

Anderson, J M2 [30]

2014

Caucasians

C-C

163

rs505151

PCR-RFLP

55 ± 10

127/44

14.7

NA

Slimani, A [31]

2014

Caucasians

C-C

258

rs505151

PCR-RFLP

Case:55 (52–65) Control:61 (55–67)

212/46

0.88

0.000

Mayne, J [32]

2013

Caucasians

Cohort

207

rs505151

PCR-RFLP

NA

NA

0.036

0.591

Aung, L H1 [33]

2013

Asians

Cohort

567

rs505151

PCR-RFLP

45.13 ± 13.35

456/111

0.021

0.60

Aung, L H2 [33]

2013

Asians

Cohort

785

rs505151

PCR-RFLP

47.36 ± 14.34

573/212

0.026

0.453

Meng yanhui [34]

2011

Asians

Cohort

165

rs505151

PCR-RFLP

66.49 ± 9.92

102/63

0.058

0.430

Zeng jian [35]

2011

Asians

C-C

212

rs505151

PCR-RFLP

NA

NA

0.123

0.020

Norata, G D [36]

2010

Caucasians

Cohort

1541

rs505151

Taqman

54.71 ± 10.97

621/923

0.024

0.32

Hsu, L A1 [37]

2009

Asians

C-C

202

rs505151

PCR-RFLP

55.6 ± 10.5

171/31

0.046

0.513

Hsu, L A2 [37]

2009

Asians

C-C

614

rs505151

PCR-RFLP

45.9 ± 10.4

325/289

0.060

0.381

Polisecki, E [38]

2008

Caucasians

Cohort

5416

rs505151

Taqman

75.64 ± 3.38

2620/2795

0.030

0.072

Scartezini, M [39]

2007

Caucasians

Cohort

2444

rs505151

PCR-RFLP

50–61

2444(M)

0.065

0.788

Evans, D [40]

2006

Caucasians

Cohort

506

rs505151

PCR-RFLP

44 ± 14

239/267

0.050

0.111

Chen, SN [41]

2005

Caucasians

Cohort

372

rs505151

PCR-RFLP

58.8 ± 7.7

310/62

0.074

0.000

Jeenduang, N1 [28]

2015

Asians

Cohort

97

rs11591147

PCR-RFLP

NA

97(M)

0.031

0.753

Jeenduang, N2 [28]

2015

Asians

Cohort

209

rs11591147

PCR-RFLP

NA

NA

0.019

0.778

Bonnefond, A [42]

2015

Caucasians

C-C

4319

rs11591147

Metabochip

46.7 ± 10.0

2272/2246

0.020

0.179

Saavedra, YG [43]

2014

Caucasians

Cohort

560

rs11591147

PCR-RFLP

37.0 ± 13.9

329/231

0.016

0.699

Guella, I [44]

2010

Caucasians

c-c

3453

rs11591147

Taqman

39.6 ± 4.9

3039/414

NA

NA

Strom, T B [45]

2010

Caucasians

Cohort

1130

rs11591147

PCR-RFLP

34 ± 13.3

536/594

NA

NA

Huang, C C [46]

2009

Caucasians

Cohort

1828

rs11591147

Taqman

25.5 ± 3.4

852/916

NA

NA

Humphries, S E [47]

2009

Caucasians

Cohort

81

rs11591147

PCR-RFLP

56 ± 3.6

81(M)

0.253

0.840

Polisecki, E [38]

2008

Caucasians

Cohort

5413

rs11591147

Taqman

75.64 ± 3.38

2619/2794

0.018

0.069

  1. Abbreviations: C-C case-control, M male, F female, MAF minor allelic frequencies, HWE Hardy-Weinberg equilibrium, NA not assess